رجوع
نطاق اليوم
KWD 30.00
KWD 30.00
نطاق 52 أسبوعًا
KWD 24.00
KWD 32.28
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 30.00
/
KWD 28.02
الإغلاق السابق
KWD 30.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 46.0 | 0.3 |
| P/B | 1.4 | 2.9 |
| ROE % | 2.9 | 3.7 |
| Net Margin % | 2.3 | 3.8 |
| Rev Growth 5Y % | -1.3 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 2.464
KWD 2.464 – KWD 2.464
|
630 M | 1 |
| FY2026 |
KWD 2.383
KWD 2.383 – KWD 2.383
|
600 M | 1 |
النقاط الرئيسية
Revenue declined -1.29% annually over 5 years
Earnings declined -68.36% over the past year
ROE of 2.94% is below average
Debt/Equity of 0.04 — conservative balance sheet
Generating 23.60M in free cash flow
P/E of 45.95 — premium valuation
النمو
Revenue Growth (5Y)
-1.29%
Revenue (1Y)-1.15%
Earnings (1Y)-68.36%
FCF Growth (3Y)-23.28%
الجودة
Return on Equity
2.94%
ROIC3.00%
Net Margin2.33%
Op. Margin3.23%
الأمان
Debt / Equity
0.04
Current Ratio2.51
Interest Coverage12.91
التقييم
P/E Ratio
45.95
P/B Ratio1.38
EV/EBITDA29.94
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.15% | Revenue Growth (3Y) | -4.47% |
| Earnings Growth (1Y) | -68.36% | Earnings Growth (3Y) | -49.63% |
| Revenue Growth (5Y) | -1.29% | Earnings Growth (5Y) | -18.90% |
| Profitability | |||
| Revenue (TTM) | 487.56M | Net Income (TTM) | 11.34M |
| ROE | 2.94% | ROA | 1.97% |
| Gross Margin | 73.58% | Operating Margin | 3.23% |
| Net Margin | 2.33% | Free Cash Flow (TTM) | 23.60M |
| ROIC | 3.00% | FCF Growth (3Y) | -23.28% |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 2.51 |
| Interest Coverage | 12.91 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 45.95 | P/B Ratio | 1.38 |
| P/S Ratio | 1.07 | PEG Ratio | -0.62 |
| EV/EBITDA | 29.94 | Dividend Yield | 0.05% |
| Market Cap | 520.87M | Enterprise Value | 471.13M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 487.56M | 493.25M | 534.24M | 455.20M | 513.58M |
| Net Income | 11.34M | 35.83M | 44.67M | 28.56M | 26.21M |
| EPS (Diluted) | 0.65 | 2.06 | 2.57 | 1.63 | 1.50 |
| Gross Profit | 358.76M | 358.08M | 379.73M | 327.62M | 394.74M |
| Operating Income | 15.74M | 42.29M | 63.45M | 46.84M | 38.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 576.33M | 590.20M | 789.49M | 770.70M | 781.82M |
| Total Liabilities | 198.15M | 198.70M | 232.15M | 238.93M | 272.65M |
| Shareholders' Equity | 378.15M | 393.66M | 557.62M | 531.74M | 509.14M |
| Total Debt | 14.97M | 13.70M | 22.17M | 12.61M | 12.43M |
| Cash & Equivalents | 64.71M | 74.04M | 250.95M | 234.50M | 234.69M |
| Current Assets | 280.99M | 286.21M | 477.83M | 452.36M | 441.46M |
| Current Liabilities | 111.82M | 126.33M | 153.19M | 158.24M | 176.55M |